Joey Azofeifa
CEO Arpeggio Bio
Seminars
Tuesday 28th October 2025
Orally Bioavailable NRF2 Molecular Glue Degrader Effective in KEAP1-Mutant Cancer
2:30 pm

CEO Arpeggio Bio